4Elster T,Beata CM,Sochaczew SD,et al.Analysis of risk factors for nosocomial infections in the Neonatal Intensive Care Unit of the Pomeranian Medical University in Szczecin in the years 2005-2008[J].Ginekol Pol,2009,80(8):609-614.
5Clinical and Laboratory Standards Institute.Performance standardsfor antimicrobial susceptibility testing:Fifteenth Information Sup-plement[S].M100-S20.CLSI,2010.
6Cheung GY,Otto M.Understanding the significance of Staphylo-coccus epidermidis bacteremia in babies and children[J].Curr OpinInfect Dis,2010,23(3):208-216.
7Souli M,Sakka V,Galani I,et al.Colonisation with vanco-mycin-and linezolid-resistant Enterococcus faecium in a univer-sity hospital:molecular epidemiology and risk factor analysis[J].Int J Antimicrob Agents,2009,33(2):137-142.
8Gomez-Gil R,Romero-Gomez MP,Garcia-Arias A,et al.Nos-ocomial outbreak of linezolid-resistant Enterococcus faecalisinfection in a tertiary care hospital[J].Diagn Microbiol InfectDis,2009,65(2):175-179.
9Sader HS,Jones RN.Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers:results ofthe Daptomycin Surveillance Program(2007-2008)[J].Di-agn Microbiol Infect Dis,2009,65(2):158-162.
